Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Ohashi

Showing results (1-10 of 445) with videos related to

Pageof 45
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2007
[International collaborative trial: from the viewpoints of statistics and data management]Yasuo Ohashi
Antimicrobial Agents and Chemotherapy|April 7, 2010
Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infectionNorio Sugaya, Yasuo Ohashi
Statistics in Medicine|June 24, 2004
Adjusting for differential proportions of second-line treatment in cancer clinical trials. Part II: an application in a clinical trial of unresectable non-small-cell lung cancerTakuhiro Yamaguchi, Yasuo Ohashi
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|September 4, 2007
Influence of an educational videotape on attitudes toward participating in cohort studies--results of a randomized controlled trialMitsuko Ishii, Yasuo Ohashi
Statistics in Medicine|June 24, 2004
Adjusting for differential proportions of second-line treatment in cancer clinical trials. Part I: structural nested models and marginal structural models to test and estimate treatment arm effectsTakuhiro Yamaguchi, Yasuo Ohashi
Biometrics|March 14, 2014
Model selection criterion for causal parameters in structural mean models based on a quasi-likelihoodMasataka Taguri, Yutaka Matsuyama, Yasuo Ohashi
Statistics in Medicine|August 11, 2006
An autoregressive linear mixed effects model for the analysis of longitudinal data which show profiles approaching asymptotesIkuko Funatogawa, Takashi Funatogawa, Yasuo Ohashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2006
[Japan Arteriosclerosis Longitudinal Study]Yasuo Ohashi, Hirotsugu Ueshima, Akiko Harada
BMC Cancer|April 22, 2018
Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trialSeiji Ito, Yasuo Ohashi, Mitsuru Sasako
Clinical Trials (London, England)|September 13, 2007
Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study)Mizuki Yoshida, Yutaka Matsuyama, Yasuo Ohashi, et al.
Pageof 45

Showing results (1-10 of 445) with videos related to

Sort By:
Pageof 45
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 16, 2007
[International collaborative trial: from the viewpoints of statistics and data management]Yasuo Ohashi
Antimicrobial Agents and Chemotherapy|April 7, 2010
Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infectionNorio Sugaya, Yasuo Ohashi
Statistics in Medicine|June 24, 2004
Adjusting for differential proportions of second-line treatment in cancer clinical trials. Part II: an application in a clinical trial of unresectable non-small-cell lung cancerTakuhiro Yamaguchi, Yasuo Ohashi
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|September 4, 2007
Influence of an educational videotape on attitudes toward participating in cohort studies--results of a randomized controlled trialMitsuko Ishii, Yasuo Ohashi
Statistics in Medicine|June 24, 2004
Adjusting for differential proportions of second-line treatment in cancer clinical trials. Part I: structural nested models and marginal structural models to test and estimate treatment arm effectsTakuhiro Yamaguchi, Yasuo Ohashi
Biometrics|March 14, 2014
Model selection criterion for causal parameters in structural mean models based on a quasi-likelihoodMasataka Taguri, Yutaka Matsuyama, Yasuo Ohashi
Statistics in Medicine|August 11, 2006
An autoregressive linear mixed effects model for the analysis of longitudinal data which show profiles approaching asymptotesIkuko Funatogawa, Takashi Funatogawa, Yasuo Ohashi
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2006
[Japan Arteriosclerosis Longitudinal Study]Yasuo Ohashi, Hirotsugu Ueshima, Akiko Harada
BMC Cancer|April 22, 2018
Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trialSeiji Ito, Yasuo Ohashi, Mitsuru Sasako
Clinical Trials (London, England)|September 13, 2007
Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study)Mizuki Yoshida, Yutaka Matsuyama, Yasuo Ohashi, et al.
Pageof 45